Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Saturday, February 11, 2017

Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults any news?

Shit, more equivocation, more studies needed. Because SOMEONE ELSE WILL SOLVE THE PROBLEM. Damn it all, show some leadership. Make a fucking recommendation and protocol. What is the downside?
Current Opinion in Clinical Nutrition & Metabolic Care, 02/07/2017
Cederholm T – This article was composed with the targets to investigate the effect of fish intake and omega–3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults. It was concluded that the gathered knowledge demonstrates that healthy populations may have preventive benefits from fish and docosahexaenoic acid intake, like older adults with memory complaints/mild cognitive impairment, and may be subgroups of patients with mild/moderate Alzheimer's disease may also show such benefits. Still, more studies are required.
  • One prospective cohort study showed that seafood consumption was related to less neuritic plaques and neurofibrillary tangles in brain autopsies from elderly care residents.
  • In a large 5-year intervention no effects on cognition could be shown either in n-3 FA supplemented or in control patients.
  • Two meta-analyses in community-dwelling patients support preservation of cognition with higher fish intake.
  • Older adults with memory complaints may improve cortical blood flow during memory challenges by n-3 FA supplementation.
  • Recalculations from a report in Alzheimer's disease patients indicated a dose–response pattern between increments of serum n-3 FAs and cognitive improvement.
  • Still, a Cochrane review (using three randomized control trials) concluded that n-3 FAs cannot provide any 6-month benefit in patients with mild/moderate Alzheimer's disease.
Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report

No comments:

Post a Comment